(PDF) Erratum To: Anti-CarP Antibodies as Promising Marker

Erratum To: Anti-CarP Antibodies as Promising Marker to Measure Joint Damage and Disease Activity in Patients With Rheumatoid Arthritis

Immunologic Research - United States

doi 10.1007/s12026-015-8642-4

Full Text

Abstract

Available in full text

Categories

Date

March 22, 2015

Authors

Maria Infantino

Francesca Meacci

Mariangela Manfredi

Maurizio Benucci

Gabriella Lakos

Tommaso Schioppo

Pier-Luigi Meroni

Publisher

Springer Science and Business Media LLC

Related search

The Association of Anti-CCP Antibodies With Disease Activity in Rheumatoid Arthritis

Rheumatology International

English

Serum Resistin in Lean Rheumatoid Arthritis Patients: Does It Correlate With Disease Activity and Radiological Joint Damage?

Egyptian Journal of Rheumatology and Clinical Immunology

English

Relationship Between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients With Rheumatoid Arthritis

International Journal of Medical Sciences

English

A5.4 Anti Carbamylated Protein Antibodies (Anti-CarP) Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis

Annals of the Rheumatic Diseases

Molecular Biology

English

The Use of Interleukin-22 as a Novel Marker of Disease Activity in Female Patients With Rheumatoid Arthritis

Sohag Medical Journal

English

Joint Damage Is Amplified in Rheumatoid Arthritis Patients With Positive Thyroid Autoantibodies

Molecular Biology

Biological Sciences

English

Diagnostic Value of Anti-Cyclic Citrullinated Peptide Antibodies to Detect Rheumatoid Arthritis in Patients With Sjogren's Syndrome

Annals of the Rheumatic Diseases

Molecular Biology

English

Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities

Arthritis and Rheumatology

English

Rheumatoid Arthritis Treatment: The Earlier the Better to Prevent Joint Damage

English